Stem cell therapy for Alport syndrome: the hope beyond the hype. - Wikidata - awgldk - TriplyDB

Stem cell therapy for Alport syndrome: the hope beyond the hype.

Stem cell therapy for Alport syndrome: the hope beyond the hype.

http://www.wikidata.org/entity/Q37463203

about

Stem cell therapies benefit Alport syndrome.A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.Outcomes of male patients with Alport syndrome undergoing renal replacement therapy.Injection of amniotic fluid stem cells delays progression of renal fibrosis.Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative.COL4A6 is dispensable for autosomal recessive Alport syndrome.Feasibility of repairing glomerular basement membrane defects in Alport syndrome.Glomerular diseases: genetic causes and future therapeutics.Alport syndrome--insights from basic and clinical research.Danger control programs cause tissue injury and remodeling.The regenerative potential of parietal epithelial cells in adult mice.Four danger response programs determine glomerular and tubulointerstitial kidney pathology: clotting, inflammation, epithelial and mesenchymal healing.From Patient to Dish and Back Again: Are We There Yet?The 2014 International Workshop on Alport Syndrome.Evaluation of the ability of bone marrow derived cells to engraft the kidney and promote renal tubular regeneration in mice following exposure to cisplatin.

P2860

Q33561731-70B2F73A-FC8F-4F9A-A8B6-AE7F7155480C Q33692564-50BBDAB8-1ECB-47DF-90ED-29557A94DE65 Q34301017-7DF70075-F3FB-4159-B304-04E21EC0CE9A Q35853316-DB98B81C-60C0-466C-828D-E3ED09DDB967 Q36420940-222C2569-66F1-45BD-8614-ECBCC3B8DA2B Q37063978-E776EFF2-2DCC-4DB3-A579-ACD91C8E8B81 Q37670342-A2B12DD1-8D83-4E93-89E4-A10C1989C999 Q37774243-A2868E5A-E132-40E9-AA81-8CBC122E2AAF Q38061008-29C77BBC-E920-406E-8B3C-F32C1DF43602 Q38113929-043AB25F-53F4-49F4-B44A-127688E6CBD8 Q38545021-0BADDF2D-7088-4DC4-8E34-AF57EBEC8BAD Q39603954-5BF84853-07CC-4ECD-AEAB-65D88A5FCD35 Q42407771-7D4699F2-8F3A-47FC-AB54-F68F5E343FB0 Q42924514-D6977A51-D57F-4A95-AEC4-CFB97A4DCDE2 Q47630938-AFDAA2B5-3898-4445-A49A-78B70E799545

P2860

Stem cell therapy for Alport syndrome: the hope beyond the hype.

http://www.wikidata.org/entity/Q37463203

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Stem cell therapy for Alport syndrome: the hope beyond the hype.

@en

Stem cell therapy for Alport syndrome: the hope beyond the hype.

@nl

type

label

Stem cell therapy for Alport syndrome: the hope beyond the hype.

@en

Stem cell therapy for Alport syndrome: the hope beyond the hype.

@nl

prefLabel

Stem cell therapy for Alport syndrome: the hope beyond the hype.

@en

Stem cell therapy for Alport syndrome: the hope beyond the hype.

@nl

P1433

Q37463203-8302E823-B5E8-4897-A478-C37BC3C517AC

P1476

Q37463203-ABF83C09-D852-4C47-A858-FD606886C8BE

P2093

Q37463203-23BE9142-CAB8-4DC0-BE98-DB7929E49482

Q37463203-26CB4E6A-3FEB-4873-9133-E491EDEBAF9D

Q37463203-27F34B0E-9E9C-4ECB-8FA5-DE7A54BDF712

Q37463203-471994FA-92AA-441D-ABEF-7B4133A945B7

Q37463203-7522E467-CA6D-4ADF-90BD-0B5FCA110C0E

Q37463203-78308FF1-5CB1-4D26-9B49-25BE94EE353C

Q37463203-7A35FAAD-C610-426E-86B4-B09C7836A86E

Q37463203-7A6EFAAF-3523-4D8F-B962-91C5E68531EC

Q37463203-8B3053A1-F9E0-44A4-9738-24EACA6C6D87

Q37463203-9B5ABCA8-45A4-4716-9C6C-8502063E5AB8

P2860

Q37463203-1F1B1324-F499-417F-B05F-4ED64A9CD2A6

Q37463203-4C0E7F38-7DD6-4867-98FD-2E1CC0107798

Q37463203-520158C1-BA74-4610-A7B0-40771CE59057

Q37463203-6200B55C-4DFC-48B2-8B1A-0752B224B4AB

Q37463203-6A6CE3DB-921A-4483-B40F-E8FBBF8292F6

Q37463203-7AD2A144-D00A-4B7E-8478-04E76E8F3385

Q37463203-7CF17867-A413-437A-AE89-79CC7E48818A

Q37463203-7E959BF5-ED52-44AF-B542-9E4CEF1B4C5B

Q37463203-AA669183-A653-42C8-94BD-4FBCCEC16D52

Q37463203-BBE3156A-6DC3-451A-BFC1-2AA13A9F9DF1

P304

Q37463203-28AA3922-7810-4881-9364-AF670C0D5CC5

P31

Q37463203-45A1481C-75EE-4A4B-9E55-5EDBFD730F8D

P356

Q37463203-679DBCB3-0BDF-424F-A073-35EE8CF7EB0A

P407

Q37463203-135C8C9B-C449-4230-8BEF-62FEA0A50C65

P433

Q37463203-D462C028-BCC1-4556-902A-4E03454DF240

P478

Q37463203-DCFCA1EF-D7AB-4B99-89D3-747A6F2FA2E6

P50

Q37463203-3D7BEBC4-A869-4F1B-85C5-7C310198AA54

Q37463203-4EACE0BC-8FF3-4DA9-8448-086DD6470709

Q37463203-5559F493-1156-4271-837B-482DB76F666E

Q37463203-73261A41-6B81-4460-BC74-1C78D4BB0312

Q37463203-9D2448A7-062E-4A29-8DFA-A307CEF551E1

Q37463203-B3AD4565-BDD0-4FB0-A5C1-DE8CB13A06E7

Q37463203-BE129373-AA02-42DA-A8F2-708F955F8D87

Q37463203-D870AEC6-29D7-484A-B311-7A0060331319

Q37463203-F5220466-1A43-4657-AC5C-D70861B471C5

P577

Q37463203-B42C28BA-25F8-4C34-94A6-DEBA5F8E198E

P5875

Q37463203-20FBB904-2EB4-4A79-8CAD-6594C4D85B71

P698

Q37463203-5EBC7378-B8BD-4989-9D62-531D91FE2929

P932

Q37463203-7D459137-B9D6-4AA7-9861-8153E4B464EB

P356

P1433

Nephrology Dialysis Transplantation

P1476

Stem cell therapy for Alport syndrome: the hope beyond the hype.

@en

P2093

Christoph Licht

http://www.w3.org/2001/XMLSchema#string

Clifford Kashtan

http://www.w3.org/2001/XMLSchema#string

Dale R Abrahamson

http://www.w3.org/2001/XMLSchema#string

Dominic Cosgrove

http://www.w3.org/2001/XMLSchema#string

George Lees

http://www.w3.org/2001/XMLSchema#string

Jeffrey H Miner

http://www.w3.org/2001/XMLSchema#string

Jie Ding

http://www.w3.org/2001/XMLSchema#string

Karl Tryggvason

http://www.w3.org/2001/XMLSchema#string

Manfred Weber

http://www.w3.org/2001/XMLSchema#string

Martin Gregory

http://www.w3.org/2001/XMLSchema#string

P2860

Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease.

Alport's syndrome, Goodpasture's syndrome, and type IV collagen.

Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys

Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.

Irradiation prolongs survival of Alport mice

Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome.

Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice.

Mouse model of X-linked Alport syndrome.

Determinants of vascular permeability in the kidney glomerulus.

Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.

P304

731-734

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFN722

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Corinne Antignac

Dorin-Bogdan Borza

Marie-Claire Gubler

Hans-Joachim Anders

Laurence Heidet

Billy G. Hudson

P577

2008-12-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23707161

http://www.w3.org/2001/XMLSchema#string

P698

19110486

http://www.w3.org/2001/XMLSchema#string

P932

3888105

http://www.w3.org/2001/XMLSchema#string